Exelixis Inc (NASDAQ: EXEL) kicked off on Tuesday, up 0.19% from the previous trading day, before settling in for the closing price of $36.38. Over the past 52 weeks, EXEL has traded in a range of $19.20-$36.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 17.31% over the past five years. While this was happening, its average annual earnings per share was recorded 154.84%. With a float of $278.44 million, this company’s outstanding shares have now reached $302.79 million.
Let’s look at the performance matrix of the company that is accounted for 1310 employees. In terms of profitability, gross margin is 96.25%, operating margin of 25.16%, and the pretax margin is 28.82%.
Exelixis Inc (EXEL) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Exelixis Inc is 2.50%, while institutional ownership is 87.73%. The most recent insider transaction that took place on Nov 22 ’24, was worth 352,700. In this transaction EVP, Commercial of this company sold 10,000 shares at a rate of $35.27, taking the stock ownership to the 278,665 shares. Before that another transaction happened on Nov 22 ’24, when Company’s Officer proposed sale 10,000 for $35.27, making the entire transaction worth $352,700.
Exelixis Inc (EXEL) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported 0.33 earnings per share (EPS), higher than consensus estimate (set at 0.31) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 154.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.96% during the next five years compared to -21.77% drop over the previous five years of trading.
Exelixis Inc (NASDAQ: EXEL) Trading Performance Indicators
Take a look at Exelixis Inc’s (EXEL) current performance indicators. Last quarter, stock had a quick ratio of 3.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.00. Likewise, its price to free cash flow for the trailing twelve months is 24.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.57, a number that is poised to hit 0.39 in the next quarter and is forecasted to reach 1.64 in one year’s time.
Technical Analysis of Exelixis Inc (EXEL)
Exelixis Inc (NASDAQ: EXEL) saw its 5-day average volume 1.72 million, a negative change from its year-to-date volume of 2.07 million. As of the previous 9 days, the stock’s Stochastic %D was 82.00%. Additionally, its Average True Range was 0.87.
During the past 100 days, Exelixis Inc’s (EXEL) raw stochastic average was set at 98.18%, which indicates a significant increase from 90.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.77% in the past 14 days, which was lower than the 36.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.25, while its 200-day Moving Average is $24.89. Nevertheless, the first resistance level for the watch stands at $36.69 in the near term. At $36.92, the stock is likely to face the second major resistance level. The third major resistance level sits at $37.37. If the price goes on to break the first support level at $36.01, it is likely to go to the next support level at $35.56. The third support level lies at $35.33 if the price breaches the second support level.
Exelixis Inc (NASDAQ: EXEL) Key Stats
The company with the Market Capitalisation of 10.41 billion has total of 285,579K Shares Outstanding. Its annual sales at the moment are 1,830 M in contrast with the sum of 207,770 K annual income. Company’s last quarter sales were recorded 539,540 K and last quarter income was 117,970 K.
